The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune gene profiling of pretreatment tumor samples in "real-world" advanced melanoma patients treated with anti-PD-1 and/or anti-CTLA-4.
 
Elisa A. Rozeman
Travel, Accommodations, Expenses - MSD; NanoString Technologies
 
Marnix Heimen Geukes Foppen
Travel, Accommodations, Expenses - MSD
 
SuFey Ong
Employment - NanoString Technologies
Travel, Accommodations, Expenses - NanoString Technologies
 
Ruben Lacroix
No Relationships to Disclose
 
Patrick Danaher
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
 
Annegien Broeks
No Relationships to Disclose
 
Alessandra Cesano
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
 
Sofie Wilgenhof
No Relationships to Disclose
 
Johannes V. Van Thienen
Travel, Accommodations, Expenses - Roche
 
John B. A. G. Haanen
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Neon Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD (Inst)
 
Sarah Warren
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche
 
Christian U. Blank
Stock and Other Ownership Interests - Verastem
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche